(VTUS)Ventrus Biosciences seeing continued strength (+19% today, +53% past two trading days) 3.31 +0.58 : The biotech company provided an investor update in presentation slides last week (Jan 22) that reaffirmed funding through key milestones. Co confirmed it has sufficient cash for the completion of the VEN 307 development program
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.